ImmunityBio (IBRX) Sof foyda bo'yicha sotuv rentabelligi

ImmunityBio, Inc. (IBRX) tovar belgisi

ImmunityBio, Inc. (IBRX) kompaniyasining operatsion sof foyda marjasi Anktiva ishga tushirilishining ta'sirini ko'rsatmoqda va joriy ko'rsatkich -607.80 ni tashkil etadi. Yuqori R&D xarajatlari va tartibga soluvchi organlar tomonidan rad etilish xavfi moliyaviy tebranishlarni keltirib chiqarmoqda. Biroq, FDA tasdig'i keng ko'lamli bemorlar bazasiga kirish imkoniyatini berdi, bu esa ushbu noyob terapiyaga bo'lgan barqaror talabni va foydani tezkor ravishda oshirish imkoniyatini ta'minlaydi.

IBRX: NantKwest Kompaniyaning sof rentabelligi 04.07.2022 - 19.11.2026

ImmunityBio, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:immunitybio.com - IBRX
ImmunityBio Corp yetakchi tovari

ImmunityBio, Inc. (IBRX) kompaniyasining sof foydaning umumiy daromadga nisbati sifatida hisoblanadigan savdo marjasi daromadni real kapitalga aylantirish samaradorligini belgilaydi va hozirgi qiymati -607.80 ga yetdi. Sof foyda marjasidagi tendentsiya Patrick Soon-Shiong'ning Anktiva dori vositasini tijoratlashtirishdagi muvaffaqiyatini aks ettiradi, bu esa investorlarga ushbu ko'rsatkichdan foydalanib, qat'iy operatsion nazorat ostida biznes modelini kengaytirishning haqiqiy qobiliyatini baholash imkonini beradi.

Raqobatchilar tahlili

Immunocore Corp (IMCR) - Sof marja|Sof marja Janux Pharma (JANX)|Sof foyda bo'yicha sotuv rentabelligi RCUS|ZYME - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi TNGX (Tango Pharma)|Kompaniyaning sof rentabelligi IOVA|Sotuvning sof marjinal rentabelligi IMTX (Immatics)|Sof foyda normasi XNCR|compasstherapeutics.com - Sotuvning sof marjinal rentabelligi|Sof marja Replimune Inc.|Lyell Immunopharma (LYEL) - Sof marja|Innate Pharma S.A. - Sof foyda normasi|PYXS (Pyxis) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi cgen.com|Sof marja IO Biotech (IOBT)|STRO: Sof foyda marjasi|MiNK Therapeutics Inc. - Sof foyda bo'yicha sotuv rentabelligi|werewolftx.com (HOWL) - Sof marja|Immix Biopharma Inc. - Sotuvning sof marjinal rentabelligi|ALXO - Sotuvning sof marjinal rentabelligi|CUE: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PDSB|Sof marja Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)